News | May 11, 2023
FSD Pharma completes dosing of first cohort in Phase I clinical trial of Lucid-MS
Lucid-MS is a new drug candidate for the treatment of multiple sclerosis
Lucid-MS is a new drug candidate for the treatment of multiple sclerosis
Pheezee is designed to assess musculoskeletal and neuromuscular health.
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Super-Bond is made up of a polymerization initiator, a liquid and a polymer powder
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
Subscribe To Our Newsletter & Stay Updated
